Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIVBusiness Wire • 06/29/26
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 06/26/26
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC's ‘Final Trades'Benzinga • 06/26/26
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder CancerZacks Investment Research • 06/25/26
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)Business Wire • 06/25/26
Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBCZacks Investment Research • 06/24/26
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder CancerBusiness Wire • 06/24/26
Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis StudyZacks Investment Research • 06/23/26
Merck and Mae Partner to Expand Doula Workforce and Address Maternal Health Disparities in High-Risk U.S. MarketsBusiness Wire • 06/23/26
Bank of America Sees Interest Rates Exploding Higher Soon: Play It Safe With 4 Dividend Giants24/7 Wall Street • 06/23/26
Merck's Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)Business Wire • 06/22/26
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 06/18/26
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal DiseaseBusiness Wire • 06/18/26
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All AgesBusiness Wire • 06/17/26
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV PreventionZacks Investment Research • 06/16/26